Development and characterization of recA mutants of Campylobacter jejuni for inclusion in attenuated vaccines.
about
The RecA protein as a model molecule for molecular systematic studies of bacteria: comparison of trees of RecAs and 16S rRNAs from the same speciesFunctional characterization of excision repair and RecA-dependent recombinational DNA repair in Campylobacter jejuniThe complete Campylobacter jejuni transcriptome during colonization of a natural host determined by RNAseq.Identification of Campylobacter jejuni promoter sequences.Involvement of a plasmid in virulence of Campylobacter jejuni 81-176.Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model.Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and HelicobacterIsolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH.Nested DNA inversion of Campylobacter fetus S-layer genes is recA dependent.Cj0011c, a periplasmic single- and double-stranded DNA-binding protein, contributes to natural transformation in Campylobacter jejuni.Host-pathogen interactions in Campylobacter infections: the host perspective.Role of Cj1211 in natural transformation and transfer of antibiotic resistance determinants in Campylobacter jejuni.Advances in Campylobacter biology and implications for biotechnological applications.Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-kappaB.N-linked protein glycosylation is required for full competence in Campylobacter jejuni 81-176.A DNase encoded by integrated element CJIE1 inhibits natural transformation of Campylobacter jejuni.The food-borne pathogen Campylobacter jejuni depends on the AddAB DNA repair system to defend against bile in the intestinal environment.
P2860
Q24635216-CCBCB63B-775D-465F-A9CA-2AEE27711B6EQ28484957-CA35B135-3308-4FB2-98D5-518F223CAA34Q31133769-7AE5D45F-F292-46A8-9496-4B9C0D929761Q32127848-AF56034B-D7BB-4B36-9F7B-E10EB120CC47Q34007504-00F0AFD8-1541-483F-81E5-7B9F4FD20C2CQ34007536-F8803D51-95AA-48F2-961F-8292E1498FA6Q34713695-B60292A0-B741-4F67-AE95-F0F23AC13252Q35416384-228C2769-2FFC-4A15-A3E8-8FDBB65CCA27Q35633751-9244C4C2-8BE6-4563-9062-79190C5DADFDQ36314209-26DF84C3-DB69-4517-A69B-909710D2201BQ36803887-451B9738-504B-4F7A-8C57-83C9355B88F5Q36803989-2F6B78A6-A7E9-4CCB-82B2-7E58B773C373Q37273503-B979A75B-98C8-4613-B775-3163C09F36FAQ39958738-E0F9451B-21E8-4920-ACC9-C73479A6EA96Q39996122-4C79B292-7D1C-4C87-B54A-5DEB0FDD68EAQ41963718-186675AF-3B27-4F4D-A028-14320CD994CCQ46271282-374386E9-E12A-4666-AB0A-D5B0434D5C8D
P2860
Development and characterization of recA mutants of Campylobacter jejuni for inclusion in attenuated vaccines.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Development and characterizati ...... lusion in attenuated vaccines.
@ast
Development and characterizati ...... lusion in attenuated vaccines.
@en
type
label
Development and characterizati ...... lusion in attenuated vaccines.
@ast
Development and characterizati ...... lusion in attenuated vaccines.
@en
prefLabel
Development and characterizati ...... lusion in attenuated vaccines.
@ast
Development and characterizati ...... lusion in attenuated vaccines.
@en
P2093
P2860
P1476
Development and characterizati ...... lusion in attenuated vaccines.
@en
P2093
P2860
P304
P407
P577
1994-02-01T00:00:00Z